Dihydrocodeinone enol acetate

Dihydrocodeinone enol acetate

Dihydrocodeinone enol acetate, also known as Thebacon or Acedicon, is a semi-synthetic opioid similar in structure to hydrocodone. It is a derivative of codeine in which the 6-7 double bond has been reduced and the 3-hydroxyl group has been acetylated.

Chemistry

Dihydrocodeinone enol acetate is a codeine derivative, part of the class of opioids known as morphinans. The chemical structure includes a 6-7 double bond, which is reduced, and a 3-hydroxyl group, which is acetylated. This results in a compound with potent analgesic properties.

Pharmacology

Thebacon's analgesic properties come from its action on the mu opioid receptor. Like other opioids, it works by binding to these receptors in the brain and spinal cord, blocking the transmission of pain signals. Thebacon also has a cough suppressant effect, due to its action on the cough center in the medulla.

Medical uses

Dihydrocodeinone enol acetate is used for the relief of moderate to severe pain and as a cough suppressant. It is typically administered orally, and is available in tablet form. Thebacon is often combined with other medications, such as acetaminophen, to enhance its analgesic effects and reduce the risk of misuse.

Side effects

Common side effects of Thebacon include drowsiness, nausea, and constipation. Like other opioids, it has a high potential for addiction and dependence, and its use should be closely monitored by a healthcare professional.

Legal status

In many countries, including the United States, Thebacon is a controlled substance. It is classified as a Schedule II drug under the Controlled Substances Act, indicating that it has a high potential for abuse and dependence, but also has accepted medical uses.

See also

• Hydrocodone
• Codeine
• Opioid
• Controlled Substances Act

‎